IL1R1 and neoplasm: A murine experimental breast cancer model showed that treatment with anakinra (a recombinant form of IL-1RA with FDA approval for the treatment of rheumatoid arthritis and cryopyrin-associated periodic syndromes) reduced the size and number of bone metastases as well as tumor angiogenesis [165].